[Central serous chorioretinopathy: A review]

J Fr Ophtalmol. 2023 Sep;46(7):791-802. doi: 10.1016/j.jfo.2023.02.003. Epub 2023 Jun 3.
[Article in French]

Abstract

The central serous chorioretinopathy (CSCR) is characterized by serous retinal detachments SRD associated with one or several retinal pigment epithelium detachments/irregularities (PEDs). The choroid is thickened with dilated choroidal veins and choroidal hyperpermeability suggesting an underlying choroidopathy. CSCR belongs to the pachychoroid spectrum. CSCR affects mostly middle-aged men and the main risk factor is the corticosteroid intake. In most cases, the subretinal detachment resolves spontaneously with a good visual prognosis. However, recurrent or chronic form of the disease can lead to irreversible retinal damage and decreased visual acuity. Laser on an extra foveal leak point or half dose/half fluence photodynamic therapy are the first-line treatment options.

Keywords: Central serous chorioretinopathy; Choriorétinopathie séreuse centrale; Choroidopathy; Choroïdopathie; Décollement de l’épithélium pigmentaire; Décollement séreux rétinien; Laser; Photodynamic therapy; Photothérapie dynamique; Pigment epithelium detachment; Serous retinal detachment.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Central Serous Chorioretinopathy* / complications
  • Central Serous Chorioretinopathy* / diagnosis
  • Central Serous Chorioretinopathy* / epidemiology
  • Chronic Disease
  • Fluorescein Angiography
  • Humans
  • Male
  • Middle Aged
  • Retina
  • Retinal Detachment* / diagnosis
  • Retinal Detachment* / etiology
  • Retinal Detachment* / therapy
  • Retrospective Studies
  • Tomography, Optical Coherence